Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

BMRNBMRN
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in BIOMARIN PHARMACEUTICAL INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.6M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $92.5M as of 2026-Q2. The position was increased (+1.8% shares). BMRN represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$92.5M

Current Shares

1.6M

Total Value Change

-$6.1M

Total Shares Change

+214,392

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+1.8%
$92.5M0.0%$57.22
30
2026-Q1
Increased
1.6M
+11.5%
$89.7M0.0%$56.49
33
2025-Q4
Increased
1.4M
+1.9%
$84.6M0.0%$59.43
30
2025-Q3
Decreased
1.4M
-10.2%
$75.7M0.0%$54.16
0
2025-Q2
Increased
1.6M
+1.6%
$85.5M0.0%$54.97
30
2025-Q1
Increased
1.5M
+7.6%
$108.3M0.0%$70.69
32
2024-Q4
Increased
1.4M
+1.6%
$93.6M0.0%$65.73
30
2024-Q3
Increased
1.4M
+4.1%
$98.5M0.0%$70.29
31

Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used